IRAKM and Mincle in ALD

IRAKM 和 Mincle 在 ALD 中

• 批准号: 8912063
• 负责人: Xiaoxia Li
• 金额: $ 43.81万
• 依托单位: CLEVELAND CLINIC LERNER COM-CWRU
• 依托单位国家: 美国
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-06-01 至 2020-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8912063
• 关键词: Affect; Alcohol abuse; Alcoholic Liver Diseases; Alcohols; American; Animal Model; BCL10 gene; Biochemical; C Type Lectin Receptors; Cell Death; Cessation of life; Chronic; Cirrhosis; Complex; Data; Development; Disease Progression; Dose; Ethanol; Family; Fibrosis; Foundations; Future; Genes; Genetic; Goals; Hepatic; Hepatitis; Hepatocyte; IRAK1 gene; IRAK2 gene; IRAK4 gene; Indium; Inflammation; Inflammatory; Inflammatory Response; Injury; Interleukin-1; Intestines; Kupffer Cells; Lead; Ligands; Link; Lipopolysaccharides; Liver; Liver Circulation; MAP3K7 gene; Mediating; Molecular; Morbidity - disease rate; Mus; Myeloid Cells; Pathogenesis; Pathway interactions; Patients; Permeability; Phosphotransferases; Post-Transcriptional Regulation; Prevention; Primary carcinoma of the liver cells; Production; Regulation; Reporting; Research Project Grants; Role; Signal Transduction; Source; Stimulus; TNF gene; Testing; Therapeutic; Therapeutic Intervention; Time; Translations; Up-Regulation; Work; alcohol exposure; base; chemokine; cytokine; design; endoplasmic reticulum stress; extracellular; feeding; fibrogenesis; human IRAK3 protein; improved; injured; interest; macrophage; member; mitochondrial dysfunction; mortality; mouse model; pre-clinical; preclinical study; problem drinker; public health relevance; response; response to injury; sensor; stellate cell; toll-like receptor 4; upstream kinase

 DESCRIPTION (provided by applicant): Alcoholic liver disease (ALD) is a major source of alcohol-related morbidity and mortality. It is estimated that 10-15 percent of alcoholics develop fibrosis, cirrhosis and hepatocellular carcinoma. Inflammatory responses are critical contributors to disease progression. One important pathway to increased inflammation results from increased intestinal permeability and changes in bacterial microflora, resulting in activation of Toll-like receptor 4 (TLR4) on Kupffer cells. However, ethanol also directly injures hepatocytes; our preliminary data indicate that signals from injured hepatocytes are also critical to the activation of hepatic macrophages. The overall objective of this proposal is to investigate how TLR-dependent inflammatory responses, in combination with alcohol-induced hepatocellular injury, coordinately lead to pathogenesis of ALD. TLRs transduce their signals through the adaptor molecule MyD88 and members of the IL-1R-associated kinase (IRAK) family, including IRAK1, IRAK2, IRAKM and IRAK4. IRAK4, the upstream kinase, directly interacts with MyD88. While MyD88- IRAK4-IRAK1 mediates TAK1-dependent NFB activation, MyD88-IRAK4-IRAK2 is critical for post- transcriptional control. While IRAKM interacts with MyD88-IRAK4 to mediate a MEKK3-dependent second wave NFB activation, it interacts with IRAK2 to inhibit translation of cytokines and chemokines. Thus, IRAKM exerts an overall inhibitory effect on inflammatory responses. Surprisingly, we found IRAKM-deficient mice were protected from ethanol-induced liver injury. Array analysis led us to be interested in one particular TLR4-induced IRAKM-dependent gene, Mincle, a C-type lectin receptor, that senses non-homeostatic cell death, thereby inducing pro-inflammatory cytokine and chemokine production. Mincle expression was induced in liver of ALD patients and in mice after ethanol feeding in an IRAKM-dependent pathway. Further, Mincle-deficient mice were protected from ethanol-induced liver injury. Since Mincle is a sensor for cell death and its expression is IRAKM-dependent, we hypothesize that TLR-induced IRAKM-dependent Mincle up-regulation in Kupffer cells provides a critical link between alcohol-induced cell death and onset of inflammatory responses, contributing to the pathogenesis of ALD. To test this hypothesis, we propose the following Aims: Aim 1 Investigate the mechanism for TLR-mediated IRAKM-dependent pathway in ALD: we will investigate (1) The molecular mechanism for the TLR-MyD88-IRAKM-MEKK3-dependent pathway induced by low dose of TLR ligands; (2) The mechanism for the pathogenic role of the TLR-MyD88-IRAKM-MEKK3-dependent pathway in ALD. Aim 2 Investigate the mechanism by which Mincle-mediated signaling contributes to ALD: We will investigate (1) The molecular mechanism for Mincle-mediated inflammasome activation; (2) The cellular mechanism for the pathogenic role of the Mincle-dependent pathway in ALD. These combined molecular/cellular and pre-clinical studies will identify critical elements in the role of the TLR-IRAK-M-Mincle signaling in ALD, leading to improved therapeutics for prevention and treatment of ALD.